Clinical Trial Update: A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate the safety and how nitroglycerin affects the body when taken with Nurandociguat in people with stable coronary artery disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)
• Nurandociguat (nurandociguat)

Snippet

Sponsor: Bayer | Conditions: Stable Coronary Artery Disease | Phase 1 | Status: NOT_YET_RECRUITING